Physical Activity and Health Outcomes Three Months After Completing a Physical Activity Behavior Change Intervention: Persistent and Delayed Effects
Overview
Oncology
Public Health
Authors
Affiliations
Purpose: We previously reported the effectiveness of a 12-week physical activity behavior change intervention for breast cancer survivors postintervention with this report, aiming to determine delayed and/or persistent effects 3 months after intervention completion.
Methods: Forty-one sedentary women with stage I, II, or IIIA breast cancer currently receiving hormonal therapy were randomly assigned to receive the 12-week Better Exercise Adherence after Treatment for Cancer intervention or usual care. Assessments occurred at baseline, postintervention, and 3 months postintervention.
Results: Weekly minutes of greater than or equal to moderate intensity physical activity measured by accelerometer showed a significant group by time interaction (F = 3.51; P = 0.035; between group difference in the mean change from baseline to 3 months postintervention, 100.1 minute, P = 0.012). Significant group by time interactions also showed sustained improvements from baseline to 3 months postintervention in strength (F = 3.82; P = 0.027; between group difference, 11.2 kg; P = 0.026), waist-to-hip ratio (F = 3.36; P = 0.041; between group difference, -0.04; P = 0.094), and social well-being (F = 4.22; P = 0.023; between group difference, 3.9; P = 0.039). A delayed reduction in lower extremity dysfunction 3 months postintervention was noted (F = 3.24; P = 0.045; between group difference in the mean change from postintervention to 3 months follow-up; P = -7.6; P = 0.015). No group by time effect was noted for fitness, body mass index, percent fat, bone density, total quality of life (Functional Assessment of Cancer Therapy-General), fatigue, endocrine symptoms, cognitive function, or sleep.
Conclusions: The intervention resulted in sustained improvements in physical activity, strength, central adiposity, and social well-being with lower extremity function benefits appearing 3 months after intervention completion. Testing translation in a multisite study is warranted.
Cardiovascular training versus resistance training for fatigue in people with cancer.
Oeser A, Messer S, Wagner C, Wender A, Cryns N, Brockelmann P Cochrane Database Syst Rev. 2024; 9:CD015519.
PMID: 39229865 PMC: 11372854. DOI: 10.1002/14651858.CD015519.pub2.
Reis F, Pereira A, Almeida E, Cecatto R, Brito C Rev Assoc Med Bras (1992). 2024; 70(suppl 1):e2024S120.
PMID: 38865540 PMC: 11164265. DOI: 10.1590/1806-9282.2024S120.
The Use of Wearable Devices in Oncology Patients: A Systematic Review.
Chow R, Drkulec H, Im J, Tsai J, Nafees A, Kumar S Oncologist. 2023; 29(4):e419-e430.
PMID: 37971410 PMC: 10994271. DOI: 10.1093/oncolo/oyad305.
Lucas A, Kim Y, Lanoye A, Franco R, Sutton A, LaRose J Cancer Med. 2023; 12(19):20094-20105.
PMID: 37768040 PMC: 10587924. DOI: 10.1002/cam4.6581.
A scoping review of studies exploring physical activity and cognition among persons with cancer.
Brunet J, Sharma S J Cancer Surviv. 2023; 18(6):2033-2051.
PMID: 37561316 DOI: 10.1007/s11764-023-01441-x.